SUSAN ANDREA: Open Payments
NPI 1902966039 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 33 payments from 19 companies in 2025. Trend: 2023 $1,214 · 2024 $754 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $164 |
| AstraZeneca Pharmaceuticals LP | 3 | $81 |
| Edwards Lifesciences Corporation | 3 | $80 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| PFIZER INC. | 2 | $40 |
| HARMONY BIOSCIENCES LLC | 1 | $30 |
| SANOFI PASTEUR INC. | 1 | $26 |
| Antares Pharma, Inc. | 1 | $26 |
| Amneal Pharmaceuticals LLC | 1 | $25 |
| Seqirus USA Inc | 1 | $25 |
Products named: UBRELVY, SYNTHROID, Sunosi, VRAYLAR, FARXIGA, BREZTRI, WAKIX, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE.
Industry payments across MA — which companies pay providers there.
